AU2003226401A8 - Gelsolin as a prognostic marker of artherosclerotic diseases - Google Patents
Gelsolin as a prognostic marker of artherosclerotic diseasesInfo
- Publication number
- AU2003226401A8 AU2003226401A8 AU2003226401A AU2003226401A AU2003226401A8 AU 2003226401 A8 AU2003226401 A8 AU 2003226401A8 AU 2003226401 A AU2003226401 A AU 2003226401A AU 2003226401 A AU2003226401 A AU 2003226401A AU 2003226401 A8 AU2003226401 A8 AU 2003226401A8
- Authority
- AU
- Australia
- Prior art keywords
- gelsolin
- prognostic marker
- artherosclerotic
- diseases
- artherosclerotic diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37304302P | 2002-04-16 | 2002-04-16 | |
US60/373,043 | 2002-04-16 | ||
PCT/US2003/011722 WO2003088811A2 (en) | 2002-04-16 | 2003-04-16 | Gelsolin as a prognostic marker of artherosclerotic diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003226401A1 AU2003226401A1 (en) | 2003-11-03 |
AU2003226401A8 true AU2003226401A8 (en) | 2003-11-03 |
Family
ID=29250950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003226401A Abandoned AU2003226401A1 (en) | 2002-04-16 | 2003-04-16 | Gelsolin as a prognostic marker of artherosclerotic diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003226401A1 (en) |
WO (1) | WO2003088811A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9408891B2 (en) | 2003-11-12 | 2016-08-09 | The Trustees Of The University Of Pennsylvania | Methods of using gelsolin to treat or prevent bacterial sepsis |
PL1755661T3 (en) | 2004-05-12 | 2014-10-31 | Brigham & Womens Hospital Inc | Gelsolin for use in treating infections |
CA2567223A1 (en) | 2004-05-19 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Treatment of diseases associated with altered level of amyloid beta peptides |
WO2007106577A2 (en) | 2006-03-15 | 2007-09-20 | The Brigham And Women's Hospital, Inc. | Gelsolin in the treatment and diagnosis of neurological disease |
PT3279663T (en) | 2006-03-15 | 2021-09-24 | Brigham & Womens Hospital Inc | Use of gelsolin to diagnose and treat inflammatory diseases |
ES2634263T3 (en) | 2008-01-25 | 2017-09-27 | The General Hospital Corporation | Therapeutic diagnostic uses of gelsolin in renal failure |
RU2563987C2 (en) * | 2010-10-20 | 2015-09-27 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Biomarker for alzheimer's disease or mild cognitive impairment |
EP2725360A1 (en) * | 2012-10-24 | 2014-04-30 | Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca | Biomarkers for the prognosis of ischemic stroke |
CN103242304A (en) * | 2013-05-21 | 2013-08-14 | 苏州科捷生物医药有限公司 | Synthetic method of anti-inflammatory drug tenidap sodium |
CN107300589A (en) * | 2017-04-18 | 2017-10-27 | 广州仁恒医药科技股份有限公司 | A kind of chromatographic purity assay method of Difluprednate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU663050B2 (en) * | 1990-04-11 | 1995-09-28 | Brigham And Women's Hospital | Therapeutic uses of actin-binding compounds |
-
2003
- 2003-04-16 WO PCT/US2003/011722 patent/WO2003088811A2/en not_active Application Discontinuation
- 2003-04-16 AU AU2003226401A patent/AU2003226401A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003226401A1 (en) | 2003-11-03 |
WO2003088811A3 (en) | 2004-02-26 |
WO2003088811A2 (en) | 2003-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1048854B (en) | Improved timepiece | |
HK1090435A1 (en) | World timepiece | |
AU2003210829A8 (en) | Battery-powered wristwatch | |
PT1470732T (en) | Provision of location information | |
HK1062202A1 (en) | Watchcase | |
GB2394323B (en) | High-throughput uart interfaces | |
AU2003226401A8 (en) | Gelsolin as a prognostic marker of artherosclerotic diseases | |
GB0200738D0 (en) | Improvements relating to illuminated jewellery | |
GB0210368D0 (en) | Marker pens | |
HK1083518A1 (en) | Coloured labels | |
AU2003270113A8 (en) | Isolated mapping point | |
GB0210159D0 (en) | Improvements relating to signal enhancement | |
AU2003233286A1 (en) | Pth derivatives resistant to skin proteases | |
IL148158A0 (en) | Marker for sign | |
IL163578A0 (en) | Use of the mal protein as a tumour marker | |
EP1573055A4 (en) | Genetic diagnosis of depression | |
GB2386189B (en) | Movement gauge | |
GB0228694D0 (en) | Novel threapeutic target | |
AU2003211311A1 (en) | A fat mesuring scale | |
AU2003226975A1 (en) | Analysis of a protein expression pattern | |
GB0312052D0 (en) | Marker bouy | |
AU2002241209A1 (en) | Provision of location information | |
GB0221063D0 (en) | Improvements relating to information processing | |
GB0200244D0 (en) | Improvements relating to information recordal | |
GB0214272D0 (en) | Improvements relating to information recordal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |